MedTrace Logo

The CROCO Study: CROhn's Disease COhort Study

NCT05420233 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2024-12-11

No results posted yet for this study

Summary

The investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target strategy, will be closely followed to characterize the progression of Crohn Disease by measuring the Lémann Index over time. The goal of the CROCO Study - "Crohn's Disease Cohort Study" is to promote a greater understanding of the long-term evolution of Crohn Disease , to describe prospectively the impact of different therapeutic strategies and develop accurate predictors of bowel disease damage and disability.

Conditions

  • Crohn Disease

Interventions

DIAGNOSTIC_TEST

MRE

Magnetic Resonance Enterography at year 1 (in some patients)

Sponsors & Collaborators

  • AbbVie

    collaborator INDUSTRY

  • GLSMED Learning Health S.A.

    lead OTHER

Principal Investigators

  • Joana T Torres, Phd · Luz Saude

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2030-07-31
Completion
2030-07-31

Countries

  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • France
  • Italy
  • Malta
  • Portugal
  • Romania
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05420233 on ClinicalTrials.gov